This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Centro Nacional de Genotipado | |
|---|---|
| Name | Centro Nacional de Genotipado |
| Established | 1999 |
| Type | Research institute |
| Location | Madrid, Spain |
| Affiliations | Spanish National Cancer Research Centre, Consejo Superior de Investigaciones Científicas, Universidad Autónoma de Madrid |
Centro Nacional de Genotipado is a Spanish high-throughput genotyping center founded to support large-scale genetic studies in human and non-human organisms. The center provided infrastructure for array-based genotyping, next-generation sequencing, and bioinformatics pipelines that served researchers across Spanish and international institutions. It operated within national research networks and contributed to consortium-based projects that linked population cohorts, clinical consortia, and model organism initiatives.
The center was created in the late 1990s amid initiatives similar to projects such as the Human Genome Project, HapMap Project, 1000 Genomes Project, International HapMap Consortium, and national genomics efforts in countries like United States, United Kingdom, Germany, and Japan. Early governance drew on experience from institutions such as the Centro Nacional de Investigaciones Oncológicas, the Consejo Superior de Investigaciones Científicas, and universities including Universidad Autónoma de Madrid and Universidad Complutense de Madrid. Initial technology adoption paralleled instruments and platforms from companies associated with projects at Wellcome Trust Sanger Institute, Broad Institute, European Bioinformatics Institute, and collaborations with clinical centers such as Hospital Universitario La Paz and Hospital Universitario 12 de Octubre. The center’s role evolved alongside consortia like the GENEVA Consortium, the Biobanking and Biomolecular Resources Research Infrastructure, and European programs such as Horizon 2020.
The center’s mission focused on enabling genotyping capacity for cohorts, clinical trials, and basic research aligned with initiatives like Spanish National Health System translational research, population genetics consortia comparable to Spanish National Biobank, and disease-focused networks including Spanish Cancer Research Network and the European Prospective Investigation into Cancer and Nutrition. Objectives included supporting projects similar to Genome-Wide Association Study consortia, facilitating data generation for projects akin to International Cancer Genome Consortium, and providing resources used by researchers at institutions such as Instituto de Salud Carlos III, Universitat de Barcelona, Instituto de Biomedicina de Valencia, and Centro de Investigación Príncipe Felipe.
Laboratory facilities mirrored those at leading centers such as Cold Spring Harbor Laboratory, EMBL-EBI, and the Broad Institute, featuring equipment comparable to platforms from Illumina, Affymetrix, and early next-generation systems used at Roche 454 and SOLiD sites. Core units included DNA extraction and quality control suites paralleling protocols at Wellcome Centre for Human Genetics, automated liquid handling similar to setups at Sanger Institute, and high-throughput genotyping arrays analogous to arrays used by the International HapMap Project and Genome-wide association studies. Bioinformatics infrastructure integrated compute clusters like those at Barcelona Supercomputing Center and software ecosystems drawing on tools from PLINK (software), GATK, BWA (software), and resources such as dbSNP and Ensembl.
Project portfolios included genome-wide genotyping for cohorts comparable to EPIC (European Prospective Investigation into Cancer and Nutrition), disease-focused GWAS akin to studies in coronary artery disease and type 2 diabetes mellitus consortia, pharmacogenomics efforts similar to work by CPIC, and population genetics analyses echoing studies of Iberian populations and Mediterranean cohorts linked to researchers at University of Barcelona and Centro de Regulación Genómica. The center contributed data generation supporting meta-analyses with groups such as GIANT Consortium, DIAGRAM Consortium, and CARDIoGRAMplusC4D Consortium, and participated in projects with disease networks like OncoArray Consortium and neurogenetics collaborations involving Alzheimer's Disease Neuroimaging Initiative investigators.
Collaborative partners included national institutions such as the Instituto de Salud Carlos III, regional hospitals including Hospital Clínic de Barcelona and Hospital Ramón y Cajal, universities like Universidad de Valencia, and international partners such as the Wellcome Trust Sanger Institute, the Broad Institute, and the European Bioinformatics Institute. The center engaged with consortia including International HapMap Consortium, 1000 Genomes Project, and European frameworks such as BBMRI-ERIC. Industry collaborations echoed partnerships with companies comparable to Illumina, Thermo Fisher Scientific, and reagent providers used by platforms at Genentech and Roche research facilities.
Funding sources drew on national agencies such as the Spanish Ministry of Science and Innovation, competitive grants from programs akin to Horizon 2020, research institutes like the Instituto de Salud Carlos III, and institutional support from universities including Universidad Autónoma de Madrid. Governance included oversight structures similar to those at Consejo Superior de Investigaciones Científicas research centers, advisory boards with academic representatives from institutions such as Pompeu Fabra University and University of Oxford, and compliance with standards set by entities like European Research Council frameworks.
The center enabled large-scale genotyping that supported publications in journals and communities linked to organizations such as Nature Genetics, The Lancet, PLoS Genetics, and research networks like GIANT and CARDIoGRAM. Its contributions advanced population genetics, disease association mapping, pharmacogenomics, and biobank genotyping workflows used by entities like Spanish National Biobank and international consortia including BBMRI-ERIC. By providing centralized high-throughput services similar to those at Broad Institute and Sanger Institute, the center accelerated research outputs from Spanish institutions such as Centro Nacional de Investigaciones Oncológicas and Institut d'Investigacions Biomèdiques August Pi i Sunyer and supported translational projects involving hospitals like Hospital Universitario La Paz and Hospital Clínic de Barcelona.
Category:Genomics research institutes in Spain